ArticleBMC ophthalmology2025
Changes in choriocapillaris blood flow density and associated factors affecting axial elongation in Chinese children and adolescents with mild to moderate myopia: a cross-sectional study.
Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Age Modifies the Comparative Effectiveness of DIMS Versus HAL Spectacle Lenses for Myopia Control: A Real-World Study.Translational vision science & technology · 2026Article
- Localized Choriocapillaris Flow Deficits at Perforating Vessel Sites in Myopic Eyes.Investigative ophthalmology & visual science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundTo investigate changes in choriocapillaris blood flow density (CFD) and identify factors influencing axial elongation in Chinese children and adolescents with mild to moderate myopia.
methodsA hospital-based cross-sectional study was conducted. A total of 288 participants aged 8 to 15 years were recruited from Tianjin Eye Hospital, including 186 children and adolescents with myopia and 102 age-matched participants without refractive error who served as the control group. Based on cycloplegic spherical equivalent (SE), the myopic participants were further categorized into moderate and mild myopia groups. Refractive power was determined through refraction tests, while various parameters-including axial length (AL) and choriocapillaris flow density (CFD)-were obtained through ophthalmic examinations. Statistical analyses were performed to examine changes in CFD and to identify factors associated with axial length.
resultsAL and SE differed significantly among all three groups (all P < 0.001). SFCT was significantly lower in the moderate myopia group compared to the mild myopia and control groups (P < 0.05 for both comparisons), while no significant differences in SFCT or FRT were found between the mild myopia and control groups(all P > 0.05).CFD-peri was significantly lower in the moderate myopia group compared to both the mild myopia and control groups (P = 0.006 and P < 0.001, respectively), while no significant differences were found in CFD-fovea or CFD-para among the three groups(P > 0.05).Spearman correlation analysis revealed significant negative correlations between AL and SE (r = -0.770), SFCT (r = -0.170), CFD-fovea (r = -0.347), CFD-para (r = -0.368), and CFD-peri (r = -0.359) (all P < 0.01). Hierarchical regression analysis identified SE (β = -0.751, P < 0.001) and CFD-peri (β = -0.118, P = 0.005) as independent predictors of axial length, with the final model explaining 71.5% of its variance (R² = 0.715).
conclusionChoriocapillaris blood flow density in the macular region changes in the early stages of myopia, showing decreases in the perifoveal region. Both SE and CFD-peri may serve as potential biomarkers for predicting axial length elongation in the early stage of myopia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.